Section 34-20A-110 – Immunity from arrest or prosecution for reporting person in need of emergency medical assistance for drug-related overdose.
34-20A-110. Immunity from arrest or prosecution for reporting person in need of emergency medical assistance for drug-related overdose. No person may be arrested or prosecuted for any misdemeanor or felony offense of possession, inhalation, ingestion, or otherwise taking into the body any controlled drug or substance if that person contacts any law enforcement or emergency […]
Section 34-20A-111 – Immunity from arrest or prosecution for reporting one’s own need for emergency medical assistance for drug-related overdose.
34-20A-111. Immunity from arrest or prosecution for reporting one’s own need for emergency medical assistance for drug-related overdose. A person who experiences a drug-related overdose and is in need of medical assistance may not be arrested, charged, or prosecuted for any misdemeanor or felony offense of possession, inhalation, ingestion, or otherwise taking into the body […]
Section 34-20A-87 – Habeas corpus available at any time.
34-20A-87. Habeas corpus available at any time. A person committed under this chapter may at any time seek to be discharged from commitment by writ of habeas corpus. Source: SL 1974, ch 240, §12 (l).
Section 34-20A-112 – Providing first aid or other medical assistance as mitigating factor–Limitations on immunity.
34-20A-112. Providing first aid or other medical assistance as mitigating factor–Limitations on immunity. Providing first aid or other medical assistance to someone who is experiencing a drug-related overdose may be used as a mitigating factor in a criminal prosecution for which immunity is not provided under §§34-20A-109 to 34-20A-113, inclusive. Nothing in §§34-20A-109 to 34-20A-113, […]
Section 34-20A-89 – Payment for treatment under involuntary commitment.
34-20A-89. Payment for treatment under involuntary commitment. If treatment of a person involuntarily committed is provided by an approved treatment facility, the payment for treatment may be assessed to the individual, to legally responsible relatives, to a conservator, to the county of residence if indigent or billed to the division through contract with the approved […]
Section 34-20A-113 – One-time immunity.
34-20A-113. One-time immunity. Any person seeking medical assistance or who reports a person is in need of medical assistance shall only qualify once for immunity under §§34-20A-109 to 34-20A-112, inclusive. Source: SL 2017, ch 154, §5.
Section 34-20A-98 – Possession and administration of opioid antagonists by first responders.
34-20A-98. Possession and administration of opioid antagonists by first responders. Any first responder trained in compliance with §34-20A-101 and acting under a standing order issued by a physician licensed pursuant to chapter 36-4 may possess and administer opioid antagonists to a person exhibiting symptoms of an opiate overdose. Source: SL 2015, ch 179, §1.
Section 34-20A-99 – Opioid antagonist defined.
34-20A-99. Opioid antagonist defined. For the purposes of §§34-20A-98 to 34-20A-103, inclusive, the term, opioid antagonist, means naloxone hydrochloride or any other similarly acting and equally safe drug approved by the federal Food and Drug Administration for the treatment of drug overdose. Source: SL 2015, ch 179, §2.
Section 34-20A-100 – First responder defined.
34-20A-100. First responder defined. For the purposes of §§34-20A-98 to 34-20A-103, inclusive, the term, first responder, includes: (1)A law enforcement officer as defined by subdivision 22-1-2(22); (2)A driver and attendant responding to an emergency call as part of an ambulance service licensed pursuant to chapter 34-11; and (3)A firefighter. Source: SL 2015, ch 179, §3.
Section 34-20A-101 – Training of first responders.
34-20A-101. Training of first responders. Each first responder authorized to administer an opioid antagonist shall be trained in the symptoms of an opiate overdose; the protocols and procedures for administration of an opioid antagonist; the symptoms of adverse responses to an opioid antagonist, and protocols and procedures to stabilize the patient if an adverse response […]